Precipio ICE-COLD PCR Kit for Sanger Sequencing
Precipio has launched a second new version of its ICE-COLD PCR enrichment kit for use in Sanger Sequencing platforms. The multiplex panel allows identification of resistance mutations in the blood of patients with non-small cell lung cancer. Adaptation of the kit for Sanger sequencing is part of a larger effort by Precipio to modify its technology to be platform-agnostic, the company said. At approximately $150 per test, Precipio believes that its technology offers significant savings compared to competing assays for the same liquid biopsy application.